Identifying Barriers and Practical Solutions to Conducting Site-Based Research in North America: Exploring Acute Heart Failure Trials As a Case Study.

[1]  G. Felker,et al.  Enrollment in Heart Failure Clinical Trials: Insights Into Which Entry Criteria Exclude Patients. , 2015, Journal of cardiac failure.

[2]  W. Kraus,et al.  Authorship in a multicenter clinical trial: The Heart Failure-A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) Authorship and Publication (HAP) scoring system results. , 2015, American heart journal.

[3]  K. Dickstein,et al.  International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT‐HF): rationale for and design of a global registry , 2015, European journal of heart failure.

[4]  E. Braunwald.  The war against heart failure: the Lancet lecture , 2015, The Lancet.

[5]  S. Solomon,et al.  Site selection for heart failure clinical trials in the USA , 2015, Heart Failure Reviews.

[6]  M. Gheorghiade,et al.  Global Perspectives in Hospitalized Heart Failure: Regional and Ethnic Variation in Patient Characteristics, Management, and Outcomes , 2014, Current Heart Failure Reports.

[7]  M. Vaduganathan,et al.  Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries. , 2014, American heart journal.

[8]  Naoki Sato,et al.  The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. , 2014, Journal of the American College of Cardiology.

[9]  A. Mebazaa,et al.  Clevidipine in acute heart failure: Results of the A Study of Blood Pressure Control in Acute Heart Failure-A Pilot Study (PRONTO). , 2014, American heart journal.

[10]  Adrian F Hernandez,et al.  Representativeness of RELAX-AHF Clinical Trial Population in Acute Heart Failure , 2014, Circulation. Cardiovascular quality and outcomes.

[11]  D. J. Veldhuisen,et al.  Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions , 2014, Heart Failure Reviews.

[12]  M. Gheorghiade,et al.  Need for increased awareness and evidence-based therapies for patients hospitalized for heart failure. , 2013, JAMA.

[13]  M. Gheorghiade,et al.  The role of the emergency department in acute heart failure clinical trials--enriching patient identification and enrollment. , 2013, American heart journal.

[14]  I. Piña,et al.  Forecasting the Impact of Heart Failure in the United States: A Policy Statement From the American Heart Association , 2013, Circulation. Heart failure.

[15]  M. Gheorghiade,et al.  Strategies and opportunities for drug development in heart failure. , 2013, JAMA.

[16]  K. Swedberg,et al.  Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial. , 2013, Journal of the American College of Cardiology.

[17]  C. O'connor,et al.  Implications of geographical variation on clinical outcomes of cardiovascular trials. , 2012, American heart journal.

[18]  P. Adams.  Site-based research in acute heart failure. , 2011, Heart failure clinics.

[19]  W. Gibler,et al.  Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association. , 2010, Circulation.

[20]  G. Fonarow,et al.  National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities. , 2010, Journal of the American College of Cardiology.

[21]  K. Sliwa,et al.  The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study. , 2010, European heart journal.

[22]  Mark D. Huffman,et al.  Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association , 2009, Circulation.

[23]  V. Hasselblad,et al.  Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF). , 2009, American heart journal.

[24]  Nancy M Albert,et al.  Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. , 2006, JAMA.

[25]  S. Werns.  Effect of Nesiritide in Patients with Acute Decompensated Heart Failure , 2012 .

[26]  W. Frishman,et al.  Systolic Blood Pressure at Admission, Clinical Characteristics, and Outcomes in Patients Hospitalized With Acute Heart Failure , 2007 .